Clinical Trials Browser

Phase 1 × Unknown × CTL019 chimeric antigen receptor × Clear all

NCT03101709 2017-04-05

The Safety and Efficacy of CART-19 Cells in Relapse and Refractory Patients With CD19+ B-cell Lymphoma

Phase 1 Unknown

Lymphoma, B-Cell

NCT02810223 2016-10-14

Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma